Medical device and MedTech insights, news, tips and more

hiQ Labs Granted Access to LinkedIn Public Information by Federal Judge

August 15, 2017

hiQ Labs

hiQ LabsA U.S. federal judge on Monday ruled that Microsoft’s LinkedIn unit cannot prevent a startup from accessing public profile data, in a test of how much control a social media site can wield over information its users have deemed to be public.

U.S. District Judge Edward Chen in San Francisco granted a preliminary injunction request brought by hiQ Labs, and ordered LinkedIn to remove within 24 hours any technology preventing hiQ from accessing public profiles.

“To the extent LinkedIn has already put in place technology to prevent hiQ from accessing these public profiles, it is ordered to remove any such barriers,” Chen’s order reads.

LinkedIn plans to challenge the decision, a company spokeswoman said.

“We’re disappointed in the court’s ruling,” the spokeswoman said. “This case is not over. We will continue to fight to protect our members’ ability to control the information they make available on LinkedIn.”

The dispute between the two tech companies has been going on since May, when LinkedIn issued a letter to hiQ Labs instructing the startup to stop scraping data from its service.

HiQ Labs responded by filing a suit against LinkedIn in June, alleging that the Microsoft-owned social network was in violation of antitrust laws. HiQ Labs uses the LinkedIn data to build algorithms capable of predicting employee behaviors, such as when they might quit.

The case is considered to have implications beyond LinkedIn and hiQ Labs and could dictate just how much control companies have over publicly available data that is hosted on their services.

Read More at the Source: LinkedIn: Judge Says HiQ Labs Can Use Its Data | Fortune.com

More insights

November 11, 2024
What is the Difference Between MedTech and TechMed?  
Learn More
March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.